Assessment of Genotoxic Effects in Nurses Handling Cytostatic Drugs

REFERENCES

• Bonassi, S., Fenech, M., Lando, C., Lin, Y.-P., Ceppi, M., Chang, W., Holland, N., Kirsch-Volders, M., Zeiger, E., Ban, S., Barale, R., Bigatti, M., Bolognesi, C., Jia, C., Di Giorgio, M., Ferguson, L., Fucic, A., Lima, O., Hrelia, P., Krishnaja, A., Lee, T.-K., Migliore, L., Mikhalevich, L., Mirkova, E., Mosesso, P., Müller, W.-U., Odagiri, Y., Scarfi, M., Szabova, E., Vorobtsova, I., Vral, A., and Zijno, A. 2001. Human MicroNucleus Project: International database comparison for results with cytokinesis-block micronucleus assay in human lymphocytes: I. Effect of laboratory protocol, scoring criteria, and host factors on the frequency of micronuclei. Environ. Mol. Mutagen. 37: 31–45.
   PubMed Web of Science ®Google Scholar
• Bolognesi, C., Lando, C., Forni, A., Landini, E., Scarpato, R., Migliori, L., and Bonassi, S. 1999. Chromosomal damage and ageing: Effect of micronuclei frequency in peripheral blood lymphocytes. Age Ageing 28: 393–397.
   PubMed Web of Science ®Google Scholar
• Bouraoui, S., Brahem, A., Tabka, F., Mrizek, N., Saad, A., and Elghezal, H. 2011. Assessment of chromosomal aberrations, micronuclei and proliferation rate index in peripheral lymphocytes from Tunisian nurses handling cytotoxic drugs. Environ. Toxicol. Pharmacol. 31: 250–257.
   PubMed Web of Science ®Google Scholar
• Buschini, A., Villarini, M., Feretti, D., Mussi, F., Dominici, L., Zerbini, I., Moretti, M., Ceretti, Bonfiglioli, R., Carrieri, M., Gelatti, U., Rossi, C., Monarca, S., and Poli, P. 2013. Multicentre study for the evaluation of mutagenic/carcinogenic risk in nurses exposed to antineoplastic drugs: Assessment of DNA damage. Occup. Environ. Med. doi:10.1136/oemed-2013-101475.
   PubMed Web of Science ®Google Scholar
• Castiglia, L., Miraglia, N., Pieri, M., Simonelli, A., Basilicata, P., Genovese, G., Guadagni, R., Acampora, A., Sannolo, N., and Scafarto, M. V. 2008. Evaluation of occupational exposure to antiblastic drugs in an Italian hospital oncological department. J. Occup. Health 50: 48–56.
   PubMed Web of Science ®Google Scholar
• Cavallo, D., Ursini, C., Rondinone, B., and Iavicoli, S. 2009. Evaluation of a suitable DNA damage biomarker for human biomonitoring of exposed workers. Environ. Mol. Mutagen. 50: 781–790.
   PubMed Web of Science ®Google Scholar
• Cavallo, D., Ursini, C. L., Omodeo-Salè, E., and Iavicoli, S. 2007. Micronucleus induction and FISH analysis in buccal cells and lymphocytes of nurses administering antineoplastic drugs. Mutat. Res. 628: 11–18.
   PubMed Web of Science ®Google Scholar
• Cavallo, D., Ursini, C., Perniconi, B., Francesco, A., Giglio, M., Rubino, F., Marinaccio, A. and Iavicoli, S. 2005. Evaluation of genotoxic effects induced by exposure to antineoplastic drugs in lymphocytes and exfoliated buccal cells of oncology nurses and pharmacy employees. Mutat. Res. 587: 45–51.
   PubMed Web of Science ®Google Scholar
• Constantinidis, T. C., Vagka, E., Dallidou, P., Basta, P., Drakopoulos, V., Kakolyris, S., and Chatzaki, E. 2011. Occupational health and safety of personnel handling chemotherapeutic agents in Greek hospitals. Eur. J. Cancer Care 20: 123–131.
   PubMed Web of Science ®Google Scholar
• Cornetta, T., Padua, L., Testa, A., Ievoli, E., Festa, F., Tranfo, G., Baccelliere, L., and Cozzi, R. 2008. Molecular biomonitoring of population of nurses handling antineoplastic drugs. Mutat. Res. 638: 75–82.
   PubMed Web of Science ®Google Scholar
• Deng, H., Zhang, M., He, J., Wu, W., Jin, L., Zheng, W., Lou, J., and Wang, B. 2005. Investigating genetic damage in workers occupationally exposed to methotrexate using three genetic endpoints. Mutagenesis 20: 351–357.
   PubMed Web of Science ®Google Scholar
• El-Ebiary, A., Abuelfadl, A. A., and Sarhan, N. 2011. Evaluation of genotoxicity induced by exposure to antineoplastic drugs in lymphocytes of oncology nurses and pharmacists. J. Appl. Toxicol. 33: 196–201.
   PubMed Web of Science ®Google Scholar
• Fenech, M., Holland, N., Chang, W., Zeiger, E., and Bonassi, S. 1999. The Human MicroNucleus Project—An international collaborative study on the use of the micronucleus technique for measuring DNA damage in humans. Mutat. Res. 428: 271–283.
   PubMed Web of Science ®Google Scholar
• Fransman, W., Vermeulen, R., and Kromhout, H. 2004. Occupational dermal exposure to cyclophosphamide in Dutch hospitals: A pilot study. Ann. Occup. Hyg. 48: 237–244.
   PubMed Web of Science ®Google Scholar
• Fucic, A., Jazbec, A., Mijic, A., Seso-Simic, D., and Tomek, R. 1998. Cytogenetic consequences after occupational exposure to antineoplastic drugs. Mutat. Res. 416: 59–66.
   PubMed Web of Science ®Google Scholar
• Gulten, T., Evke, E., Ercan, I., Evrensel, T., Kurt, E., and Manavoglu, O. 2011. Lack of genotoxicity in medical oncology nurses handling antineoplastic drugs: Effect of work environment and protective equipment. Work 39: 485–489.
   PubMedGoogle Scholar
• Hedmer, M., Tinnerberg, H., Axmon, A., and Jönsson, B. A. G. 2008. Environmental and biological monitoring of antineoplastic drugs in four workplaces in a Swedish hospital. Int. Arch. Occup. Environ. Health 81: 899–911.
   PubMed Web of Science ®Google Scholar
• Hedmer, M., Jönssona, B., and Nygren, O. 2004. Development and validation of methods for environmental monitoring of cyclophosphamide in workplaces. J. Environ. Monit. 6: 979–984.
   PubMed Web of Science ®Google Scholar
• Hedmer, M., and Wohlfart, G. 2012. Hygienic guidance values for wipe sampling of antineoplastic drugs in Swedish hospitals. J. Environ. Monit. 14: 1968–1975.
   PubMed Web of Science ®Google Scholar
• Hessel, H., Radon, K., Pethran, A., Maisch, B., Gröbmair, S., Sautter, I., and Fruhmann, G. 2001. The genotoxic risk of hospital, pharmacy and medical personnel occupationally exposed to cytostatic drugs—Evaluation by the micronucleus assay. Mutat. Res. 497: 101–109.
   PubMed Web of Science ®Google Scholar
• IARC. 1981. Some antineoplastic and immunosuppressive agents. IARC Monogr. Eval. Carcinogen. Risks Hum. Vol 26.
   Google Scholar
• Jackson, M., Stack, H. F., and Waters, M. D. 1996. Genetic activity profiles of anticancer drugs. Mutat. Res. 355: 171–208.
   PubMed Web of Science ®Google Scholar
• Kasuba, V., Rozgaj, R., and Garaj-Vrhovac, V. 1999. Analysis of sister chromatid exchange and micronuclei in peripheral blood lymphocytes of nurses handling cytostatics drugs. J. Appl. Toxicol. 19: 401–404.
   PubMed Web of Science ®Google Scholar
• Kevekordes, S., Gebel, T. W., Hellwig, M., Dames, W., and Dunkelberg, H. 1998. Human effect monitoring in cases of occupational exposure to antineoplastic drugs: A method comparison. Occup. Environ. Med. 55: 145–149.
   PubMed Web of Science ®Google Scholar
• Kiffmeyer, T., and Hadtstein, C. 2007. Handling of chemotherapeutic drugs in the OR: Hazards and safety considerations. Cancer Treat. Res. 134: 275–290.
   PubMedGoogle Scholar
• Kirsch-Volders, M., Mateuca, R., Roelants, M., Tremp, A., Zeiger, E., Bonassi, S., Holland, N., Chang, W., Aka, P., DeBoeck, M., Goddenis, L., Haufroid, V., Ishikawa, H., Laffon, B., Marcos, R., Migliore, L., Norppa, H., Teixeira, J., Zijno, A., and Fenech, M. 2006. The effects of GSTM1 and GSTT1 polymorphisms on micronucleus frequencies in human lymphocytes in vivo. Cancer Epidemiol. Biomarkers Prev. 15: 1038–1042.
   PubMed Web of Science ®Google Scholar
• Kopjar, N., Garaj-Vrhovac, V., Kasuba, V., Rozgaj, R., Ramic, S., Pavlica, V., and Zeljezic, D. 2009. Assessment of genotoxic risks in Croatian health care workers occupationally exposed to cytotoxic drugs: a multi-biomarker approach. Int. J. Hyg. Environ. Health 212: 414–431.
   PubMed Web of Science ®Google Scholar
• Kopjar, N., and Garaj-Vrhovac, V. 2001. Application of the alkaline comet assay in human biomonitoring for genotoxicity: A study on Croatian medical personnel handling antineoplastic drugs. Mutagenesis 16: 71–78.
   PubMed Web of Science ®Google Scholar
• Kopp, B., Crauste-Manciet, S., Guibert, A., Mourier, W., Guerrauly-Moro, M.-N., Ferrari, S., Jomier, J.-Y., Brossard, D., and Schierl, R. 2013. Environmental and biological monitoring of platinum-containing drugs in two hospital pharmacies using positive air pressure isolators. Ann. Occup. Hyg., 57: 374–383.
   PubMed Web of Science ®Google Scholar
• Kusnetz, E., and Condon, M. 2003. Acute effects from occupational exposure to antineoplastic drugs in a para-professional health care worker. Am. J. Ind. Med. 44: 107–109.
   PubMed Web of Science ®Google Scholar
• Ladeira, C., Viegas, S., Carolino, E., Gomes, M. C., and Brito, M. 2013. The influence of genetic polymorphisms in XRCC3 and ADH5 genes on the frequency of genotoxicity biomarkers in workers exposed to formaldehyde. Environ. Mol. Mutagen. 54: 213–221.
   PubMed Web of Science ®Google Scholar
• Ladeira, C., Viegas, S., Carolino, E., Prista, J., Gomes, M. C., and Brito, M. 2011. Genotoxicity biomarkers in occupational exposure to formaldehyde—The case of histopathology laboratories. Mutat. Res. 721: 15–20.
   PubMed Web of Science ®Google Scholar
• Laffon, B., Teixeira, J.P., Loureiro, J., Torres, J., Pásaro, E., Méndez, J. and Mayan, O. 2005. Genotoxic effects in a population of nurses handling antineoplastic drugs, and relationship with genetic polymorphisms in DNA repair enzymes. Am. J. Ind. Med. 28: 128–136.
   Web of Science ®Google Scholar
• Larson, R., Khazaeli, M., and Dillon, H. 2003. A new monitoring method using solid sorbent media for evaluation of airborne cyclophosphamide and other antineoplastic agents. Appl. Occup. Environ. Hyg. 18: 120–131.
   PubMedGoogle Scholar
• Mader, R., Kokalj, A., Kratochvil, E., Pilger, A., and Rüdiger, H. W. 2008. Longitudinal biomonitoring of nurses handling antineoplastic drugs. J. Clin. Nurs. 18: 263–269.
   Web of Science ®Google Scholar
• Mahboob, M., Rahman, M. F., Rekhavedi, P.V., Sailaja, N., Balasubramanyam, A., Prabhakar, P. V., Singh, S. P., Reddy, U. A., Rao, S., and Grover, P. 2012. Monitoring of oxidative stress in nurses occupationally exposed to antineoplastic drugs. Toxicol. Int. 19: 20–24.
   PubMedGoogle Scholar
• Maluf, S., and Erdtmann, B. 2000. Follow-up study of the genetic damage in lymphocytes of pharmacists and nurses handling antineoplastic drugs evaluated by cytokinesis-block micronuclei analysis and single cell gel electrophoresis. Mutat. Res. 471: 21–27.
   PubMed Web of Science ®Google Scholar
• Moretti, M., Bonfiglioli, R., Feretti, D., Pavanello, S., Mussi, F., Grollino, M., Villarini, M., Barbieri, A., Ceretti, E., Carrieri, M., Buschini, A., Appolloni, M., Dominici, L., Sabatini, L., Gelatti, U., Bartolucci, G., Poli, P., Stronati, L., Mastrangelo, G., and Monarca, S. 2011. A study protocol for the evaluation of occupational mutagenic/carcinogenic risks in subjects exposed to antineoplastic drugs: A multicentric project. BMC Public Health 11: 195.
   PubMed Web of Science ®Google Scholar
• NIOSH Alert. 2004. Preventing occupational exposures to antineoplastic and other hazardous drugs in health care settings. Department of Health and Human Services, Centres for Disease Control and Prevention. Natl. Inst. Occup. Safety Health 165: 1–50.
   Google Scholar
• Orsière, T., Sari-Minodier, I., Iarmarcovai, G., and Botta, A. 2006. Genotoxic risk assessment of pathology and anatomy laboratory workers exposed to formaldehyde by use of personal air sampling and analysis of DNA damage in peripheral lymphocytes. Mutat. Res. 605: 30–41.
   PubMed Web of Science ®Google Scholar
• Pilger, A., Kohler, I., Stettner, H., Mader, R.M., Rizovski, B., Terkola, R., Diem, E., Franz-Hainzl, E., Konnaris, C., Valic, E., and Rudiger, H.W. 2000. Long-term monitoring of sister chromatid exchanges and micronucleus frequencies in pharmacy personnel occupationally exposed to cytostatic drugs. Int. Arch. Occup. Environ. Health 73: 442–448
   PubMed Web of Science ®Google Scholar
• Rekhadevi, P. V., Sailaja, N., Chandrasekhar, M., Mahboob, M., Rahman, M. F., and Grover, P. 2007. Genotoxicity assessment in oncology nurses handling anti-neoplastic drugs. Mutagenesis 22: 395–401.
   PubMed Web of Science ®Google Scholar
• Schierl, R., Böhlandt, A., and Nowak, D. 2009. Guidance values for surface monitoring of antineoplastic drugs in German pharmacies. Ann. Occup. Hyg. 53: 703–711.
   PubMed Web of Science ®Google Scholar
• Schmaus, G., Schierl, R., and Funck, S. 2002. Monitoring surface contamination by antineoplastic drugs using gas chromatography-mass spectrometry and voltammetry. Am. J. Health Syst. Pharm. 59: 956–961.
   PubMed Web of Science ®Google Scholar
• Saski, M., Dakeishi, M., Hoshi, S., Ishii, N., and Murata, K. 2008. Assessment of DNA damage in japanese nurses handling antineoplastic drugs by the comet assay. J. Occup. Health 50: 7–12.
   PubMed Web of Science ®Google Scholar
• Sessink, P., and Bos, P. 1999. Drugs Hazardous to healthcare workers—Evaluation of methods for monitoring occupational exposure to cytostatic drugs. Drug Safety 20: 347–359.
   PubMed Web of Science ®Google Scholar
• Sessink, P., Kroese, E. D., van Kranen, H. J., and Bos, R. P. 1995. Cancer risk assessment for health care workers occupationally exposed to cyclophosphamide. Int. Arch. Occup. Environ. Health 67: 317–323.
   PubMed Web of Science ®Google Scholar
• Thiringer, G., Granung, G., Holmén, A., Högstedt, B., Järvholm, B., Jönsson, D., Persson, L., Wahlström, J., and Westin, J. 1991. Comparison of methods for the biomonitoring of nurses handling antitumor drugs. Scand. J. Work Environ. Health 17: 133–138.
   PubMed Web of Science ®Google Scholar
• Villarini, M., Dominici, L., Fatigoni, C., Muzi, G., Monarca, S., and Moretti, M. 2012. Biological effect monitoring in peripheral blood lymphocytes from subjects occupationally exposed to antineoplastic drugs: Assessment of micronuclei frequency. J. Occup. Health 54: 405–415.
   PubMed Web of Science ®Google Scholar
• Villarini, M., Dominici, L., Piccinini, R., Fatigoni, C., Ambrogi, M., Curti, G., Morucci, P., Muzi, G., Monarca, S., and Moretti, M. 2011. Assessment of primary, oxidative and excision repaired DNA damage in hospital personnel handling antineoplastic drugs. Mutagenesis 26: 359–369.
   PubMed Web of Science ®Google Scholar
• Ündeger, Ü., Basaran, N., Kars, A., and Güç, D. 1999. Assessment of DNA damage in nurses handling antineoplastic drugs by the alkaline COMET assay. Mutat. Res. 439: 277–285.
   PubMed Web of Science ®Google Scholar
• Ursini, C., Cavallo, D., Colombi, A., Giglio, M., Marinaccio, A., and Iavicoli, S. 2006. Evaluation of early DNA damage in healthcare workers handling antineoplastic drugs. Int. Arch. Environ. Health 80: 134–140.
   PubMed Web of Science ®Google Scholar
• Yoshida, J., Kosaka, H., Tomioka, K., and Kumagai, S. 2006. Genotoxic risks to nurses from contamination of the work environment with antineoplastics drugs in Japan. J. Occup. Health 48: 517–522.
   PubMed Web of Science ®Google Scholar
• Zietkiewicz, E., Wojda, A., and Witt, M. 2009. Cytogenetic perspective of ageing and longevity in men and women. J. Appl. Genet. 50: 261–273.
   PubMed Web of Science ®Google Scholar